Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « Drug Resistance »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Prescriptions < Drug Resistance < Drug Resistance, Multiple  Facettes :

List of bibliographic references indexed by Drug Resistance

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000D19 (2013) Susan H. Fox [Canada]Non-dopaminergic treatments for motor control in Parkinson's disease.
000D35 (2013) Carl Song [Canada] ; Melissa A. Chiasson ; Nirvana Nursimulu ; Stacy S. Hung ; James Wasmuth ; Michael E. Grigg ; John ParkinsonMetabolic reconstruction identifies strain-specific regulation of virulence in Toxoplasma gondii.
001660 (2011) Mohan Babu [Canada] ; J Javier Díaz-Mejía ; James Vlasblom ; Alla Gagarinova ; Sadhna Phanse ; Chris Graham ; Fouad Yousif ; Huiming Ding ; Xuejian Xiong ; Anaies Nazarians-Armavil ; Md Alamgir ; Mehrab Ali ; Oxana Pogoutse ; Asaf Pe'Er ; Roland Arnold ; Magali Michaut ; John Parkinson ; Ashkan Golshani ; Chris Whitfield ; Shoshana J. Wodak ; Gabriel Moreno-Hagelsieb ; Jack F. Greenblatt ; Andrew EmiliGenetic interaction maps in Escherichia coli reveal functional crosstalk among cell envelope biogenesis pathways.
001D75 (2009) Waqas Khan [Canada] ; Sughra Naz ; Abdul Qayyum RanaShortness of breath, a 'wearing-off' symptom in Parkinson's disease.
002742 (2006) Peter Giacobbe [Canada] ; Sidney H. KennedyDeep brain stimulation for treatment-resistant depression: a psychiatric perspective.
002834 (2006) Michel St-Hilaire [Canada] ; Emmanuelle Bourhis [Canada] ; Daniel Lévesque [Canada] ; Claude Rouillard [Canada]Impaired behavioural and molecular adaptations to dopamine denervation and repeated L‐DOPA treatment in Nur77‐knockout mice
002F00 (2003) Andres M. Lozano [Canada]Surgery for Parkinson's disease, the five W's: Why, who, what, where, and when
002F22 (2003) Ajit Kumar [Canada] ; ZHIGAO HUANG [Canada] ; Raul De La Fuente-Fernandez [Canada]Mechanisms of motor complications in treatment of Parkinson's disease
003868 (1998) P. Seeman [Canada] ; T. TallericoAntipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
004470 (1992) P G Forkert [Canada] ; A. Parkinson ; L G Thaete ; A M MalkinsonResistance of murine lung tumors to xenobiotic-induced cytotoxicity.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Drug Resistance" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Drug Resistance" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Drug Resistance
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022